Granulomatosis with polyangiitis (GPA) is a granulomatous disorder usually associated with vasculitis involving the small and medium-sized blood vessels that affects the upper and lower respiratory tracts and the kidneys, but almost any organ can be targeted. The typical renal involvement of GPA consists of a segmental necrotising glomerulonephritis, but, very rarely, renal disease could appear as an isolated or bilateral renal mass, requiring a differential diagnosis from neoplasms or granulomatous infections. We describe a patient who, during tests for a kidney mass, was found to have pulmonary nodules suspected to be metastasis, successfully treated with rituximab.
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab / Lo Gullo, Alberto; Bajocchi, Gianluigi; Cassone, Giulia; Cavazza, Alberto; Zanichelli, Matteo; Salvarani, Carlo. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 32:82(2014), pp. S138-S138.
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab
Cassone, Giulia;SALVARANI, CARLO
2014
Abstract
Granulomatosis with polyangiitis (GPA) is a granulomatous disorder usually associated with vasculitis involving the small and medium-sized blood vessels that affects the upper and lower respiratory tracts and the kidneys, but almost any organ can be targeted. The typical renal involvement of GPA consists of a segmental necrotising glomerulonephritis, but, very rarely, renal disease could appear as an isolated or bilateral renal mass, requiring a differential diagnosis from neoplasms or granulomatous infections. We describe a patient who, during tests for a kidney mass, was found to have pulmonary nodules suspected to be metastasis, successfully treated with rituximab.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris